U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 88

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:42489255
GRCh38:
Chr19:41985103
ATP1A3G270S, G281S, G283SCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeLikely benign
(Nov 7, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr19:42489523
GRCh38:
Chr19:41985371
ATP1A3D220V, D231V, D233VCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeUncertain significance
(Oct 28, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr19:42471892
GRCh38:
Chr19:41967740
ATP1A3L948R, L959R, L961RCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeUncertain significancecriteria provided, single submitter
4.
GRCh37:
Chr19:42492180
GRCh38:
Chr19:41988028
ATP1A3G100C, G102C, G89CCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeLikely pathogenic
(Nov 29, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr19:42473007
GRCh38:
Chr19:41968855
ATP1A3V917L, V928L, V930LCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeUncertain significance
(Nov 29, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr19:42489477
GRCh38:
Chr19:41985325
ATP1A3F235L, F246L, F248LCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99, Dystonia 12,
Alternating hemiplegia of childhood 2
Benign
(Dec 5, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr19:42482839
GRCh38:
Chr19:41978687
ATP1A3E517Q, E528Q, E530QCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not specifiedConflicting interpretations of pathogenicity
(May 4, 2022)
criteria provided, conflicting interpretations
8.
GRCh37:
Chr19:42485958
GRCh38:
Chr19:41981806
ATP1A3Dystonia 12, Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12, Developmental and epileptic encephalopathy 99
Likely benign
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr19:42472925
GRCh38:
Chr19:41968773
ATP1A3Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12, Developmental and epileptic encephalopathy 99
Likely benign
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr19:42474522
GRCh38:
Chr19:41970370
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2, Dystonia 12,
Developmental and epileptic encephalopathy 99, Dystonia 12
Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr19:42482125
GRCh38:
Chr19:41977973
ATP1A3A636T, A647T, A649TDystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Sep 29, 2022)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr19:42473723
GRCh38:
Chr19:41969571
ATP1A3Q851R, Q862R, Q864Rnot provided, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeLikely pathogenic
(Jul 20, 2023)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr19:42471803
GRCh38:
Chr19:41967651
ATP1A3Developmental and epileptic encephalopathy 99, not provided, Dystonia 12,
Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
Benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr19:42480738
GRCh38:
Chr19:41976586
ATP1A3Developmental and epileptic encephalopathy 99, Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
not provided, Alternating hemiplegia of childhood 2
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr19:42472917
GRCh38:
Chr19:41968765
ATP1A3Alternating hemiplegia of childhood 2, not provided, Developmental and epileptic encephalopathy 99,
Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
Benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr19:42490355
GRCh38:
Chr19:41986203
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2, Developmental and epileptic encephalopathy 99,
Dystonia 12, Dystonia 12
Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr19:42485723
GRCh38:
Chr19:41981571
ATP1A3Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99,
Dystonia 12, Alternating hemiplegia of childhood 2
Likely benign
(Aug 20, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr19:42485689
GRCh38:
Chr19:41981537
ATP1A3A468S, A479S, A481SCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeUncertain significance
(Sep 20, 2020)
criteria provided, single submitter
19.
GRCh37:
Chr19:42474646
GRCh38:
Chr19:41970494
ATP1A3T771I, T782I, T784ICerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromePathogenic
(Mar 2, 2020)
criteria provided, single submitter
20.
GRCh37:
Chr19:42473716
GRCh38:
Chr19:41969564
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr19:42482783
GRCh38:
Chr19:41978631
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr19:42470842
GRCh38:
Chr19:41966690
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12, not provided
Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr19:42473732
GRCh38:
Chr19:41969580
ATP1A3G859A, G861A, G848ACerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeLikely pathogenic
(May 20, 2019)
criteria provided, single submitter
24.
GRCh37:
Chr19:42482192
GRCh38:
Chr19:41978040
ATP1A3Dystonia 12, Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Alternating hemiplegia of childhood 2, Dystonia 12
Likely benign
(Jul 16, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr19:42480688
GRCh38:
Chr19:41976536
ATP1A3Dystonia 12, Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Alternating hemiplegia of childhood 2
Benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr19:42486166
GRCh38:
Chr19:41982014
ATP1A3Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99,
not provided, Alternating hemiplegia of childhood 2
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr19:42486118
GRCh38:
Chr19:41981966
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr19:42489322
GRCh38:
Chr19:41985170
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12,
not provided, Alternating hemiplegia of childhood 2
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr19:42479818
GRCh38:
Chr19:41975666
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12, not provided
Benign/Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr19:42486172
GRCh38:
Chr19:41982020
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12,
Alternating hemiplegia of childhood 2
Benign/Likely benign
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr19:42482333
GRCh38:
Chr19:41978181
ATP1A3not provided, Dystonia 12, Developmental and epileptic encephalopathy 99,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2
Benign
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr19:42482885
GRCh38:
Chr19:41978733
ATP1A3not provided, Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12, Developmental and epileptic encephalopathy 99, Alternating hemiplegia of childhood 2
Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr19:42486057
GRCh38:
Chr19:41981905
ATP1A3Inborn genetic diseases, Dystonia 12, Alternating hemiplegia of childhood 2,
Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided
Benign/Likely benign
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr19:42471896
GRCh38:
Chr19:41967744
ATP1A3G947W, G958W, G960WDystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12,
Alternating hemiplegia of childhood 2
Pathogenic/Likely pathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr19:42486076
GRCh38:
Chr19:41981924
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12, Alternating hemiplegia of childhood 2,
Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12,
Alternating hemiplegia of childhood 2
Uncertain significance
(Mar 30, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr19:42486053
GRCh38:
Chr19:41981901
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2, Dystonia 12,
Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99,
Alternating hemiplegia of childhood 2, Dystonia 12
Conflicting interpretations of pathogenicity
(Aug 15, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr19:42485916
GRCh38:
Chr19:41981764
ATP1A3Developmental and epileptic encephalopathy 99, Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
not provided, Alternating hemiplegia of childhood 2
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr19:42489247
GRCh38:
Chr19:41985095
ATP1A3Alternating hemiplegia of childhood 2, Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Developmental and epileptic encephalopathy 99, not provided
Benign/Likely benign
(Sep 1, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr19:42471438
GRCh38:
Chr19:41967286
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr19:42471849
GRCh38:
Chr19:41967697
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not specified,
not provided, Alternating hemiplegia of childhood 2, Dystonia 12
Benign/Likely benign
(May 1, 2023)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr19:42473622
GRCh38:
Chr19:41969470
ATP1A3V885I, V898I, V896IDevelopmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, ATP1A3-related condition,
not provided, Alternating hemiplegia of childhood 2, Dystonia 12
Conflicting interpretations of pathogenicity
(Jan 30, 2023)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr19:42474591
GRCh38:
Chr19:41970439
ATP1A3Developmental and epileptic encephalopathy 99, Dystonia 12, Alternating hemiplegia of childhood 2,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
Benign/Likely benign
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr19:42492253
GRCh38:
Chr19:41988101
ATP1A3Developmental and epileptic encephalopathy 99, Dystonia 12, Dystonia 12,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2, Developmental and epileptic encephalopathy 99,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided, Alternating hemiplegia of childhood 2
Benign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr19:42486121
GRCh38:
Chr19:41981969
ATP1A3Developmental and epileptic encephalopathy 99, Dystonia 12, Alternating hemiplegia of childhood 2,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided
Benign/Likely benign
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr19:42479820
GRCh38:
Chr19:41975668
ATP1A3D742Y, D753Y, D755YCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeLikely pathogenic
(Jan 6, 2017)
criteria provided, single submitter
46.
GRCh37:
Chr19:42490279
GRCh38:
Chr19:41986127
ATP1A3M154V, M167V, M165VCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeLikely pathogenic
(Jan 6, 2017)
criteria provided, single submitter
47.
GRCh37:
Chr19:42474692
GRCh38:
Chr19:41970540
ATP1A3R756C, R767C, R769CAlternating hemiplegia of childhood 2, Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Dystonia 12, Inborn genetic diseases
Pathogenic/Likely pathogenic
(May 25, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr19:42485987
GRCh38:
Chr19:41981835
ATP1A3Developmental and epileptic encephalopathy 99, Inborn genetic diseases, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12, Alternating hemiplegia of childhood 2, not provided
Benign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr19:42486262
GRCh38:
Chr19:41982110
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr19:42471446
GRCh38:
Chr19:41967294
ATP1A3V990I, V1001I, V1003IAlternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12,
Developmental and epileptic encephalopathy 99, not provided, Dystonia 12
Uncertain significance
(May 12, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr19:42479928
GRCh38:
Chr19:41975776
ATP1A3G706R, G717R, G719RCerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided, Alternating hemiplegia of childhood 2,
Dystonia 12
Conflicting interpretations of pathogenicity
(Sep 5, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr19:42498376
GRCh38:
Chr19:41994224
ATP1A3, LOC130064543Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99,
Dystonia 12, Alternating hemiplegia of childhood 2, Dystonia 12
Uncertain significance
(Oct 28, 2021)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr19:42498343-42498346
GRCh38:
Chr19:41994191-41994194
ATP1A3, LOC130064543Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99, Dystonia 12,
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood, Dystonia 12
Uncertain significance
(May 2, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr19:42498292
GRCh38:
Chr19:41994140
ATP1A3, LOC130064543Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99,
Dystonia 12, Alternating hemiplegia of childhood 2, Dystonia 12
Uncertain significance
(Nov 12, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr19:42498220
GRCh38:
Chr19:41994068
ATP1A3, LOC130064543Inborn genetic diseases, not specified, Developmental and epileptic encephalopathy 99,
Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2
Benign/Likely benign
(Apr 21, 2023)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr19:42492476
GRCh38:
Chr19:41988324
ATP1A3not specified, Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
not provided, Alternating hemiplegia of childhood 2, Dystonia 12
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr19:42492238
GRCh38:
Chr19:41988086
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign/Likely benign
(May 1, 2023)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr19:42492157
GRCh38:
Chr19:41988005
ATP1A3Developmental and epileptic encephalopathy 99, Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
not provided, Dystonia 12
Benign/Likely benign
(Aug 1, 2023)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:42492088
GRCh38:
Chr19:41987936
ATP1A3not provided, Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12, Alternating hemiplegia of childhood 2, Developmental and epileptic encephalopathy 99,
Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12
Benign/Likely benign
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr19:42490376
GRCh38:
Chr19:41986224
ATP1A3Alternating hemiplegia of childhood 2, Developmental and epileptic encephalopathy 99, not provided,
Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
Benign/Likely benign
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr19:42489154
GRCh38:
Chr19:41985002
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Aug 26, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr19:42486261
GRCh38:
Chr19:41982109
ATP1A3Developmental and epileptic encephalopathy 99, Alternating hemiplegia of childhood 2, Dystonia 12,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided
Conflicting interpretations of pathogenicity
(May 1, 2023)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr19:42486054
GRCh38:
Chr19:41981902
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Oct 15, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr19:42485895
GRCh38:
Chr19:41981743
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr19:42482888
GRCh38:
Chr19:41978736
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99, Alternating hemiplegia of childhood 2,
Dystonia 12, not provided
Benign/Likely benign
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr19:42482861
GRCh38:
Chr19:41978709
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
not provided, Dystonia 12
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr19:42482414
GRCh38:
Chr19:41978262
ATP1A3not provided, Developmental and epileptic encephalopathy 99, Dystonia 12,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2
Benign/Likely benign
(May 1, 2023)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr19:42482126
GRCh38:
Chr19:41977974
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr19:42482076
GRCh38:
Chr19:41977924
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
not provided, Dystonia 12
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr19:42474624
GRCh38:
Chr19:41970472
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr19:42474467
GRCh38:
Chr19:41970315
ATP1A3Developmental and epileptic encephalopathy 99, Alternating hemiplegia of childhood 2, not provided,
Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99,
Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2
Benign/Likely benign
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr19:42474392
GRCh38:
Chr19:41970240
ATP1A3not provided, Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12, Alternating hemiplegia of childhood 2, Developmental and epileptic encephalopathy 99,
not specified, Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12
Benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr19:42473665
GRCh38:
Chr19:41969513
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr19:42471897
GRCh38:
Chr19:41967745
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
Dystonia 12
Benign/Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr19:42471050
GRCh38:
Chr19:41966898
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2, not provided,
Dystonia 12
Benign
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr19:42470983
GRCh38:
Chr19:41966831
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2,
not provided, Dystonia 12
Benign/Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr19:42470774
GRCh38:
Chr19:41966622
ATP1A3not provided, Alternating hemiplegia of childhood 2, Developmental and epileptic encephalopathy 99,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12
Benign/Likely benign
(Feb 1, 2023)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr19:42492296
GRCh38:
Chr19:41988144
ATP1A3Developmental and epileptic encephalopathy 99, not specified, Dystonia 12,
not provided, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Alternating hemiplegia of childhood 2
Benign
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr19:42489096
GRCh38:
Chr19:41984944
ATP1A3P323S, P336S, P334Snot provided, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromePathogenic/Likely pathogenic
(Sep 17, 2020)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr19:42489089
GRCh38:
Chr19:41984937
ATP1A3G325D, G336D, G338Dnot provided, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromePathogenic/Likely pathogenic
(Feb 3, 2023)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr19:42474691
GRCh38:
Chr19:41970539
ATP1A3R756H, R769H, R767HATP1A3-associated neurological disorder, Inborn genetic diseases, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
not specified, not provided, Alternating hemiplegia of childhood 2,
Dystonia 12
Pathogenic/Likely pathogenic
(Sep 1, 2023)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr19:42489516
GRCh38:
Chr19:41985364
ATP1A3Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided, not specified,
Alternating hemiplegia of childhood 2, Dystonia 12
Benign/Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr19:42474639
GRCh38:
Chr19:41970487
ATP1A3Developmental and epileptic encephalopathy 99, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not specified,
not provided, Alternating hemiplegia of childhood 2, Dystonia 12
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr19:42474427
GRCh38:
Chr19:41970275
ATP1A3E818K, E829K, E831KInborn genetic diseases, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Pathogenic
(Mar 16, 2023)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr19:42471896
GRCh38:
Chr19:41967744
ATP1A3G947R, G958R, G960RAlternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12,
not provided, Alternating hemiplegia of childhood 2, Dystonia 12
Pathogenic
(Apr 8, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr19:42474436
GRCh38:
Chr19:41970284
ATP1A3E815K, E826K, E828KDystonic disorder, Seizure, Dyskinesia,
Neurodevelopmental delay, Developmental and epileptic encephalopathy 99, Alternating hemiplegia of childhood 2,
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12, Inborn genetic diseases,
not specified, not providedAlternating hemiplegia of childhood 2,
Dystonia 12, Oculogyric crisis, Global developmental delay,
Hemiplegia, ...see more
Pathogenic
(Dec 27, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr19:42474557
GRCh38:
Chr19:41970405
ATP1A3D801N, D812N, D814NInborn genetic diseases, Alternating hemiplegia of childhood 2, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Dystonia 12, ATP1A3-Related Disorders, not provided,
Alternating hemiplegia of childhood 2, Dystonia 12
Pathogenic
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr19:42472989
GRCh38:
Chr19:41968837
ATP1A3D923N, D936N, D934NATP1A3-associated neurological disorder, Dystonia 12, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,
Alternating hemiplegia of childhood 2, not provided, Alternating hemiplegia of childhood 2,
Dystonia 12
Pathogenic
(Aug 10, 2023)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination